Finland
· Delayed Price · Currency is EUR Biohit Oyj Company Description
Biohit Oyj, a biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide.
The company’s diagnostic tests product includes the GastroPanel Unified test panel for stomach health check; GastroPanel Four-in-One stomach test; GastroSoft software application to assist clinicians and general practitioner; Biohit Active B12, a test for measuring the levels of active vitamin B12; BIOHIT Total 25OH Vitamin D, a test for determination of vitamin D status; and Biohit Calprotectin test for measuring human calprotectin.
It also offers GastroPanel quick test NT, a quantitative immunochromatographic test for the detection of Helicobacter pylori (H.
Pylori) and atrophic gastritis; BIOHIT Celiac Quick test for diagnosis of celiac disease; Biohit ColonView Quick test, a test for detection of fecal occult blood; Biohit Helicobacter Pylori UFT300 and Helicobacter Pylori Quick test methods to detect H.
pylori infection; and Lactose Intolerance quick test to support the diagnosis of lactose intolerance in a duodenal biopsy specimen.
In addition, the company provides acetaldehyde-binding products, such as Acetium capsules that are intended for persons with a low-acid or anacidic stomach; and Acetium lozenge, which helps in quitting smoking; and monoclonal antibodies for use in the areas of cellular pathology, neurobiology, oncology, and human gastric biomarkers research.
The company was incorporated in 1988 and is headquartered in Helsinki, Finland.
| Country | Finland |
| Founded | 1988 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 46 |
| CEO | Jussi Hahtela |
Contact Details
Address: Laippatie 1 Helsinki, 00880 Finland | |
| Phone | 358 9773 861 |
| Website | biohithealthcare.com |
Stock Details
| Ticker Symbol | BIOBV |
| Exchange | Nasdaq Helsinki |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | FI0009005482 |
| SIC Code | 3821 |
Key Executives
| Name | Position |
|---|---|
| Jussi Hahtela | President and Chief Executive Officer |
| Prof. Osmo Antero Suovaniemi M.D., Ph.D. | Founder, Deputy Chief Executive Officer, Member of Scientific Advisory Board and Director |
| Jussi Sorvo | Chief Financial Officer |
| Graham Johnson B.Sc., BSc | Head of Global Sales and Marketing |
| Yulia Kubacheva | Head of Diagnostics Department - Biohit Russia |
| Ilari Patrakka Msc (Econ.) | Chief Commercial Officer |
| Panu Hendolin Ph.D. | R&D Director |